December 29, 2025 2026 Energy Conviction, GLP-1 Execution, and Turning the Page

In this final trading week of the year, Wall Street Beats looks ahead—shifting from reflection to preparation as investors position for 2026. The episode opens with a clear energy thesis. Despite oil spending much of 2025 near $60, energy equities held up, signaling that much of the bearish outlook is already priced in. Bob Morris lays out his top energy picks for 2026—spanning oil, natural gas, and integrated majors—arguing that steady demand, supply discipline, and ongoing geopolitical risk create a favorable setup even without meaningfully higher crude prices.   Healthcare takes the baton next. David Maris explains why the sector’s second-half breakout may carry into the new year, but only for companies that execute. GLP-1 drugs remain the dominant theme, with prescriptions still growing, market share consolidating around leaders, and a massive long-term opportunity emerging as pricing, access, and maintenance use evolve. The conversation also touches on international biotech optionality, tax-loss selling dynamics, and why stock selection now matters more than sector beta.   The episode closes with a candid, end-of-year tone—fatigue, family chaos, and the reality that discipline matters as much as ideas. With energy and healthcare standing out as areas of conviction, the team emphasizes patience, selectivity, and execution as the calendar turns. A thoughtful reset episode—focused less on predictions and more on positioning for what comes next. Subscribe to get more stock analysis and insights from the Beats Roundtable pros. Want more? Become a member. Join the Inner Circle and get a Seat at the Roundtable now: wallstreetbeats.com for exclusive access to our pros. Disclaimer This content has been produced by Street Beats Media, LLC (“Street Beats”) and is presented for informational purposes only. Street Beats is not a broker dealer and does not provide investment advice to individuals. None of the information contained herein constitutes an offer to sell, or solicitation of an offer to buy any security or investment vehicle, nor does it constitute an investment recommendation or legal, tax, accounting, or investment advice by Street Beats or any of its employees, officers, or agents. This information is presented without regard for individual investment preferences or risk parameters and is general, non-tailored, non-specific information. Our content is based on information from the sources believed to be reliable. Street Beats is not responsible for errors, inaccuracies, or omissions of information. The opinions and conclusions contained in this content are those of the individual expressing those opinions or conclusions and are intended solely for the use by Street Beats subscribers and the authorized recipients on the content. All investments involve a certain degree of risk and financial instrument prices can fluctuate based on several factors, including those not considered in the preparation of this content. Consult a financial professional before investing.